Read the full model comparison analysis →
随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
，详情可参考safew官方版本下载
The unique VCaaS model helps corporations solve this problem effectively. VCaaS providers employ experienced investors who offer expertise and continuity. Stability is built into the VCaaS model so corporations can concentrate on their strategic and financial and strategic objectives. As a way to become innovative, it is more effective to outsource startup investing to a VC firm. They can find the type of startups that will make the corporation more successful, efficient and effectively aligned with the corporation’s priorities.
Материалы по теме: